Melanie Kappelmann-Fenzl

8PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Experimental methods in fluid flow, heat and mass transfer
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Transcriptional Reprogramming by AP-1-Bound Cis-Regulatory Elements Is Associated with Melanoma Development.

|Nov 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche.

Laura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl

|Aug 30, 2024
Splicing control by PHF5A is crucial for melanoma cell survival.

Tina Meißgeier, Melanie Kappelmann-Fenzl, Sebastian Staebler

|Aug 03, 2022
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo.

Isabel Stüfchen, Ruth Beckervordersandforth, Stefan Fischer

|Jul 27, 2022
Knockdown of Lamin B1 and the Corresponding Lamin B Receptor Leads to Changes in Heterochromatin State and Senescence Induction in Malignant Melanoma.

Lisa Lämmerhirt, Melanie Kappelmann-Fenzl, Stefan Fischer

|Jan 21, 2022
HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma.

Markus V Heppt, Anja Wessely, Eva Hornig

Pageof 2

Frequent Collaborators

8 joint publications

Anja Katrin Bosserhoff

4 joint publications

Stefan Fischer

2 joint publications

Lisa Linck-Paulus

2 joint publications

Silke Kuphal